Brand names: Gleevec, Imkeldi Dosage form: oral tablet (100 mg; 400 mg), oral solution (80 mg/mL) Drug class: BCR-ABL tyrosine kinase inhibitorsMedically reviewed by Carmen Pope, BPharm. Last updated on Dec 11, 2024.Uses Warnings Before taking Dosage Side effects Interactions FAQ What...
Gleevec is supplied in 100 or 400 mg tablets. The dose is quite variable and depends on the disease being treated, age of patient (some doses based on mg per kilogram weight (mg/Kg). Doses usually range between 100 to 800 mg per day; high doses are divided into lower mg levels but...
Imatinib(STI571), an inhibitor of bcr-abltyrosine kinase, has become the first-line agent in the treatment of the chronic phase ofchronic myeloid leukaemiaand of locally advanced and metastaticgastrointestinal stromal tumors(GISTs) that express theCD117 antigen. The recommended dosage is 400mg/day...
Uses Imatinib Mesylate is orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively. Imatinib also known as Gleevec, Glivec, CGP-57148B, STI-571 & Imatinib Uses antineoplastic Use...
Uses Imatinib Mesylate is orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively. Imatinib also known as Gleevec, Glivec, CGP-57148B, STI-571 & Imatinib Uses Imatinib Mesylate...
Since then, the number of indicated uses for imatinib has substantially inc... EH Penn,HJ Chung,M Keller - 《Cutis》 被引量: 2发表: 2017年 Drug Eruption Induced by Imatinib Mesylate (Glivec®) We obtained a biopsy specimen of the erythema and made the diagnosis of erythema exudative ...
TCI ChemicalI0936Imatinib Mesylate >98.0%(HPLC)220127-57-1100mg$542024-03-01Buy TCI ChemicalI0936Imatinib Mesylate >98.0%(HPLC)220127-57-11g$3142024-03-01Buy Imatinib mesylate Chemical Properties,Uses,Production a small-molecule inhibitor
Dosing & Uses AdultPediatric Dosage Forms & Strengths tablet 100mg 400mg oral solution 80mg/mL Acute Lymphoblastic Leukemia (ALL) Indicated for relapsed or refractory Philadelphia chromosome positive (Ph+) ALL 600 mg PO once daily until disease progression or unacceptable toxicity Chronic Myeloid ...
28 (41%) patients receiving imatinib 400 mg, 85 (43%) receiving imatinib 800 mg, 23 (21%) receiving dasatinib, and 27 (25%) receiving nilotinib discontinued treatment for any reason. Interpretation Treatment with imatinib 800 mg or the second-generation TKIs dasatinib or nilotinib resulted in...
Gleevec is supplied in 100 or 400 mg tablets. The dose is quite variable and depends on the disease being treated, age of patient (some doses based on mg per kilogram weight (mg/Kg). Doses usually range between 100 to 800 mg per day; high doses are divided into lower mg levels but...